Less than a day remains until Oct. 17.
The sun's going to rise on a different world tomorrow, one in which medical and – importantly – recreational marijuana will be freely available for purchase and use by consenting Canadian adults from the Yukon to Newfoundland.
Investors have even more to look forward to.
The latest analyst estimates (they're consistently being revised upward) could hardly be more bullish.
Research firm Deloitte expects – once you consider the growers, the value-added product makers, the testing labs, security, tourism, exports, and all the rest – the Canadian legal cannabis market soon could reach an eye-watering $22.6 billion.
And even at this late hour, there are still some must-own stocks that American investors can buy – easily, I'd add – to leverage this historic moneymaking opportunity.
Make sure you grab shares of these today…
About the Author
Michael A. Robinson is one of the top financial analysts working today. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.